These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17935491)

  • 1. Cutaneous melanoma in genetically modified animals.
    Larue L; Beermann F
    Pigment Cell Res; 2007 Dec; 20(6):485-97. PubMed ID: 17935491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predominant formation of heavily pigmented dermal melanocytomas resembling 'animal-type' melanomas in hepatocyte growth factor (C57BL/6 x C3H)F1 mice following neonatal UV irradiation.
    Florell SR; Thomas J; Grossman D
    J Cutan Pathol; 2007 Sep; 34(9):667-74. PubMed ID: 17696912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse models for melanoma: a personal perspective.
    Becker JC; Houben R; Schrama D; Voigt H; Ugurel S; Reisfeld RA
    Exp Dermatol; 2010 Feb; 19(2):157-64. PubMed ID: 19849715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype.
    Otsuka T; Takayama H; Sharp R; Celli G; LaRochelle WJ; Bottaro DP; Ellmore N; Vieira W; Owens JW; Anver M; Merlino G
    Cancer Res; 1998 Nov; 58(22):5157-67. PubMed ID: 9823327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated ultraviolet radiation-induced carcinogenesis in hepatocyte growth factor/scatter factor transgenic mice.
    Noonan FP; Otsuka T; Bang S; Anver MR; Merlino G
    Cancer Res; 2000 Jul; 60(14):3738-43. PubMed ID: 10919643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid growth of invasive metastatic melanoma in carcinogen-treated hepatocyte growth factor/scatter factor-transgenic mice carrying an oncogenic CDK4 mutation.
    Tormo D; Ferrer A; Gaffal E; Wenzel J; Basner-Tschakarjan E; Steitz J; Heukamp LC; Gütgemann I; Buettner R; Malumbres M; Barbacid M; Merlino G; Tüting T
    Am J Pathol; 2006 Aug; 169(2):665-72. PubMed ID: 16877364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kita driven expression of oncogenic HRAS leads to early onset and highly penetrant melanoma in zebrafish.
    Santoriello C; Gennaro E; Anelli V; Distel M; Kelly A; Köster RW; Hurlstone A; Mione M
    PLoS One; 2010 Dec; 5(12):e15170. PubMed ID: 21170325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic mouse model for skin malignant melanoma.
    Kato M; Takahashi M; Akhand AA; Liu W; Dai Y; Shimizu S; Iwamoto T; Suzuki H; Nakashima I
    Oncogene; 1998 Oct; 17(14):1885-8. PubMed ID: 9778055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mouse model of melanoma driven by oncogenic KRAS.
    Milagre C; Dhomen N; Geyer FC; Hayward R; Lambros M; Reis-Filho JS; Marais R
    Cancer Res; 2010 Jul; 70(13):5549-57. PubMed ID: 20516123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal susceptibility to UV induced cutaneous malignant melanoma in a mouse model.
    Wolnicka-Glubisz A; Noonan FP
    Photochem Photobiol Sci; 2006 Feb; 5(2):254-60. PubMed ID: 16465311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fibroblast growth factor-2 is not essential for melanoma formation in a transgenic mouse model.
    Ackermann J; Beermann F
    Pigment Cell Res; 2005 Aug; 18(4):315-9. PubMed ID: 16029424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background.
    Ackermann J; Frutschi M; Kaloulis K; McKee T; Trumpp A; Beermann F
    Cancer Res; 2005 May; 65(10):4005-11. PubMed ID: 15899789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new mechanism of release from senescence: suppression of p16INK4a by beta-catenin.
    Curley DP; Bosenberg MW
    Pigment Cell Melanoma Res; 2008 Feb; 21(1):5-6. PubMed ID: 18353136
    [No Abstract]   [Full Text] [Related]  

  • 14. Constitutive activation of the ERK pathway in melanoma and skin melanocytes in Grey horses.
    Jiang L; Campagne C; Sundström E; Sousa P; Imran S; Seltenhammer M; Pielberg G; Olsson MJ; Egidy G; Andersson L; Golovko A
    BMC Cancer; 2014 Nov; 14():857. PubMed ID: 25413220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human relevance of NRAS/BRAF mouse melanoma models.
    Conde-Perez A; Larue L
    Eur J Cell Biol; 2014; 93(1-2):82-6. PubMed ID: 24342721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of early melanocytic lesions in transgenic mice predisposed to melanoma.
    Zhu H; Reuhl K; Botha R; Ryan K; Wei J; Chen S
    Pigment Cell Res; 2000 Jun; 13(3):158-64. PubMed ID: 10885674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma.
    Ohtani Y; Harada T; Funasaka Y; Nakao K; Takahara C; Abdel-Daim M; Sakai N; Saito N; Nishigori C; Aiba A
    Oncogene; 2008 Dec; 27(57):7162-70. PubMed ID: 18776920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathogenesis of malignant skin melanoma induced in genetically susceptible transgenic mice.
    Mintz B; Silvers WK; Klein-Szanto AJ
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8822-6. PubMed ID: 8415614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal UVB exposure accelerates melanoma growth and enhances distant metastases in Hgf-Cdk4(R24C) C57BL/6 mice.
    Gaffal E; Landsberg J; Bald T; Sporleder A; Kohlmeyer J; Tüting T
    Int J Cancer; 2011 Jul; 129(2):285-94. PubMed ID: 21207411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma progression in a changing environment.
    van Kempen LC; van Muijen GN; Ruiter DJ
    Eur J Cell Biol; 2007 Feb; 86(2):65-7. PubMed ID: 17241688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.